These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 27601445

  • 1. Pueraria mirifica alleviates cortical bone loss in naturally menopausal monkeys.
    Kittivanichkul D, Charoenphandhu N, Khemawoot P, Malaivijitnond S.
    J Endocrinol; 2016 Nov; 231(2):121-133. PubMed ID: 27601445
    [Abstract] [Full Text] [Related]

  • 2. Anti-osteoporotic effects of Pueraria candollei var. mirifica on bone mineral density and histomorphometry in estrogen-deficient rats.
    Suthon S, Jaroenporn S, Charoenphandhu N, Suntornsaratoon P, Malaivijitnond S.
    J Nat Med; 2016 Apr; 70(2):225-33. PubMed ID: 26815435
    [Abstract] [Full Text] [Related]

  • 3. Changes in bone mass during the perimenopausal transition in naturally menopausal cynomolgus monkeys.
    Kittivanichkul D, Watanabe G, Nagaoka K, Malaivijitnond S.
    Menopause; 2016 Jan; 23(1):87-99. PubMed ID: 26671190
    [Abstract] [Full Text] [Related]

  • 4. Pueraria mirifica, a phytoestrogen-rich herb, prevents bone loss in orchidectomized rats.
    Urasopon N, Hamada Y, Asaoka K, Cherdshewasart W, Malaivijitnond S.
    Maturitas; 2007 Mar 20; 56(3):322-31. PubMed ID: 17101247
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of Pueraria candollei var. mirifica (Airy Shaw & Suvat.) Niyomdham for menopausal women: A systematic review of clinical trials and the way forward.
    Kongkaew C, Scholfield NC, Dhippayom T, Dilokthornsakul P, Saokaew S, Chaiyakunapruk N.
    J Ethnopharmacol; 2018 Apr 24; 216():162-174. PubMed ID: 29409850
    [Abstract] [Full Text] [Related]

  • 6. Preventive effects of Pueraria mirifica on bone loss in ovariectomized rats.
    Urasopon N, Hamada Y, Cherdshewasart W, Malaivijitnond S.
    Maturitas; 2008 Feb 20; 59(2):137-48. PubMed ID: 18313241
    [Abstract] [Full Text] [Related]

  • 7. Catechin-rich oil palm leaf extract enhances bone calcium content of estrogen-deficient rats.
    Bakhsh A, Mustapha NM, Mohamed S.
    Nutrition; 2013 Apr 20; 29(4):667-72. PubMed ID: 23290096
    [Abstract] [Full Text] [Related]

  • 8. Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women.
    Manonai J, Chittacharoen A, Udomsubpayakul U, Theppisai H, Theppisai U.
    Menopause; 2008 Apr 20; 15(3):530-5. PubMed ID: 18202589
    [Abstract] [Full Text] [Related]

  • 9. Long-term resveratrol treatment prevents ovariectomy-induced osteopenia in rats without hyperplastic effects on the uterus.
    Zhao H, Li X, Li N, Liu T, Liu J, Li Z, Xiao H, Li J.
    Br J Nutr; 2014 Mar 14; 111(5):836-46. PubMed ID: 24073920
    [Abstract] [Full Text] [Related]

  • 10. Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys.
    Yamada H, Ochi Y, Mori H, Nishikawa S, Hashimoto Y, Nakanishi Y, Tanaka M, Bruce M, Deacon S, Kawabata K.
    Bone; 2016 May 14; 86():43-52. PubMed ID: 26921823
    [Abstract] [Full Text] [Related]

  • 11. Upregulation of osteoblastic differentiation marker mRNA expression in osteoblast-like UMR106 cells by puerarin and phytoestrogens from Pueraria mirifica.
    Tiyasatkulkovit W, Charoenphandhu N, Wongdee K, Thongbunchoo J, Krishnamra N, Malaivijitnond S.
    Phytomedicine; 2012 Oct 15; 19(13):1147-55. PubMed ID: 22951392
    [Abstract] [Full Text] [Related]

  • 12. A Root-Based Combination Supplement Containing Pueraria lobata and Rehmannia glutinosa and Exercise Preserve Bone Mass in Ovariectomized Rats Fed a High-Fat Diet.
    Ok HM, Gebreamanuel MR, Oh SA, Jeon H, Lee WJ, Kwon O.
    Calcif Tissue Int; 2015 Dec 15; 97(6):624-33. PubMed ID: 26319677
    [Abstract] [Full Text] [Related]

  • 13. Long-term treatment effects of Pueraria mirifica phytoestrogens on parathyroid hormone and calcium levels in aged menopausal cynomolgus monkeys.
    Trisomboon H, Malaivijitnond S, Suzuki J, Hamada Y, Watanabe G, Taya K.
    J Reprod Dev; 2004 Dec 15; 50(6):639-45. PubMed ID: 15647615
    [Abstract] [Full Text] [Related]

  • 14. Improvements of vaginal atrophy without systemic side effects after topical application of Pueraria mirifica, a phytoestrogen-rich herb, in postmenopausal cynomolgus macaques.
    Jaroenporn S, Urasopon N, Watanabe G, Malaivijitnond S.
    J Reprod Dev; 2014 Dec 15; 60(3):238-45. PubMed ID: 24748397
    [Abstract] [Full Text] [Related]

  • 15. Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density.
    Genant HK, Engelke K, Hanley DA, Brown JP, Omizo M, Bone HG, Kivitz AJ, Fuerst T, Wang H, Austin M, Libanati C.
    Bone; 2010 Jul 15; 47(1):131-9. PubMed ID: 20399288
    [Abstract] [Full Text] [Related]

  • 16. Effect of Pueraria mirifica on the sexual skin coloration of aged menopausal cynomolgus monkeys.
    Trisomboon H, Malaivijitnond S, Cherdshewasart W, Watanabe G, Taya K.
    J Reprod Dev; 2006 Aug 15; 52(4):537-42. PubMed ID: 16799265
    [Abstract] [Full Text] [Related]

  • 17. Pueraria mirifica extract and puerarin enhance proliferation and expression of alkaline phosphatase and type I collagen in primary baboon osteoblasts.
    Tiyasatkulkovit W, Malaivijitnond S, Charoenphandhu N, Havill LM, Ford AL, VandeBerg JL.
    Phytomedicine; 2014 Oct 15; 21(12):1498-503. PubMed ID: 25442257
    [Abstract] [Full Text] [Related]

  • 18. Peripheral quantitative computed tomography (pQCT) is useful for monitoring bone mineral density of the patients who receive hormone replacement therapy.
    Sawada K, Morishige K, Ohmichi M, Nishio Y, Yamamoto T, Hayakawa J, Mabuchi S, Isobe A, Sasaki H, Sakata M, Tasaka K, Murata Y.
    Maturitas; 2007 Apr 20; 56(4):343-9. PubMed ID: 17010541
    [Abstract] [Full Text] [Related]

  • 19. Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial.
    Brixen K, Chapurlat R, Cheung AM, Keaveny TM, Fuerst T, Engelke K, Recker R, Dardzinski B, Verbruggen N, Ather S, Rosenberg E, de Papp AE.
    J Clin Endocrinol Metab; 2013 Feb 20; 98(2):571-80. PubMed ID: 23337728
    [Abstract] [Full Text] [Related]

  • 20. Site-specific effects of strength training on bone structure and geometry of ultradistal radius in postmenopausal women.
    Adami S, Gatti D, Braga V, Bianchini D, Rossini M.
    J Bone Miner Res; 1999 Jan 20; 14(1):120-4. PubMed ID: 9893073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.